Analysis of cytomegalovirus DNA polymerase (UL54) mutations in solid organ transplant patients receiving valganciclovir or ganciclovir prophylaxis.
about
CMV: Prevention, Diagnosis and TherapyHow I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipientsAntiviral drug resistance of human cytomegalovirus.Valganciclovir in the treatment of cytomegalovirus retinitis in HIV-infected patients.Improving outcomes for solid-organ transplant recipients at risk from cytomegalovirus infection: late-onset disease and indirect consequences.Ganciclovir-resistant cytomegalovirus infections among lung transplant recipients are associated with poor outcomes despite treatment with foscarnet-containing regimens.Cytomegalovirus risk, prevention, and management in pediatric solid organ transplantation.Clinical aspects of cytomegalovirus antiviral resistance in solid organ transplant recipients.Human cytomegalovirus antiviral drug resistance in hematopoietic stem cell transplantation: current state of the art.Successful valganciclovir treatment of post-transplant cytomegalovirus infection in the presence of UL97 mutation N597D.Rapid detection of human cytomegalovirus UL97 and UL54 mutations directly from patient samplesThe impact of drug-resistant cytomegalovirus in pediatric allogeneic hematopoietic cell transplant recipients: a prospective monitoring of UL97 and UL54 gene mutations.Diversity of antiviral-resistant human cytomegalovirus in heart and lung transplant recipients.Rapid detection and quantitation of ganciclovir resistance in cytomegalovirus quasispecies.
P2860
Q26824869-8F1F861D-86C2-402D-8DC1-FCC20592F408Q28069489-05E47646-C1DD-40E3-9FA6-3F36DF93F6F3Q30430427-ACAFB9CF-E0EC-4688-BAC6-270C333B1BC6Q33715300-5E4A16B1-D25E-49F3-AA59-479D2A983C9AQ37065216-7987A74A-FE25-4C98-B334-51D16CC79EEBQ37544353-CD1FF14E-9F15-48BA-A430-EEB24B3AF230Q37825594-2C5B317B-2B55-403C-8FF4-22420105FD63Q38067694-723DDC76-3A65-41C9-BC92-02EF812D175AQ38779846-43CE4476-C553-4885-92E2-5C2C6F77A697Q40399325-F13E158D-BBF1-4E04-85B5-8EFE5686CC69Q41430486-ADBCA207-F3BE-4775-89AD-6B2003E0364BQ41657330-840051DF-002F-4597-B542-77914B0B2BD8Q44411974-2AB75B0B-5FB3-493E-AD87-850CD67AA7DBQ48039802-10329604-8AD7-45EA-9FFA-761C834FDA7C
P2860
Analysis of cytomegalovirus DNA polymerase (UL54) mutations in solid organ transplant patients receiving valganciclovir or ganciclovir prophylaxis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Analysis of cytomegalovirus DN ...... ir or ganciclovir prophylaxis.
@en
Analysis of cytomegalovirus DNA polymerase
@nl
type
label
Analysis of cytomegalovirus DN ...... ir or ganciclovir prophylaxis.
@en
Analysis of cytomegalovirus DNA polymerase
@nl
prefLabel
Analysis of cytomegalovirus DN ...... ir or ganciclovir prophylaxis.
@en
Analysis of cytomegalovirus DNA polymerase
@nl
P2093
P356
P1476
Analysis of cytomegalovirus DN ...... ir or ganciclovir prophylaxis.
@en
P2093
Christian Gilbert
Emma Covington
Guy Boivin
Nathalie Goyette
P304
P356
10.1002/JMV.20471
P577
2005-11-01T00:00:00Z